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Editorial on the Research Topic
Bioactive Compounds fromMicrobes
Microorganisms are ubiquitous and essentially interact with all the other organisms present in the
biosphere, sometimes creating a network of signals that constitutes the basis for life on the Earth.
Clarifying the nature of these molecular signals, their targets and the pathways underlying their
production, constitutes the essential pre-requisite for deciphering inter-kingdom communications,
adaptive responses and systems biology (Nicholson et al., 2012; O’Mahony et al., 2015; Cani
and Knauf, 2016). The insights acquired in the last two decades about human microbiota, and
its fundamental role in maintaining a healthy physiological status, have opened the way to
understanding the complex reciprocal talk between bacteria and humans (Hughes and Sperandio,
2008; Lyte and Freestone, 2010; Mayer, 2011; Cryan and Dinan, 2012; Mazzoli, 2014; Halang et al.,
2015; Kelly et al., 2015). In parallel with these aspects, new bioactive molecules from the microbial
world that interact with different cellular models continue to be discovered.
The times and the technological advances start now to be suitable for intercellular/interorganism
communication to be studied at the molecular level. The aim of the present topic issue is to try to
describing the mediator molecules of a network of signals which is still largely underexplored and
underexploited.
As an example, some soil bacteria (such as Serratia spp.) can have antagonistic actions toward
worms and the molecule involved, zeamine, is effective against yeasts and other biological systems,
as well. Prodigiosin, the well-known pigment produced by the marine bacterium Vibrio ruber, has a
broad antimicrobial spectrum and induces autolytic activity in the target cells (i.e., Bacillus subtilis).
Lantibiotics are class I bacteriocins produced by Gram-positive bacteria that can be bioengineered
to both enhance their effectiveness against a larger number of bacterial strains and to improve their
stability during the gastric transit that is by rendering them protease-resistant. These overall data
open new possibilities for antibiotic therapy in a period in which the phenomenon of antibiotic
resistance is considered as a major threat to public health (World Health Organization, 2014)
since it is widespread in pathogenic, commensal, and food bacteria (Laxminarayan et al., 2013).
Furthermore, the appearance of multiresistant bacterial strains (the so-called superbugs), often
causing death, clearly constitutes a serious problem to be solved. Exploiting the microbial world
and its huge potential in finding new antimicrobial drugs is an urgent concern and some chapters
of this topic issue deal with these aspects.
Other interesting molecules are produced by cytomegalovirus-infected cells: these compounds
of viral origin (essentially proteins) can promote virus dissemination, persistence, and pathogenesis
by counteracting host innate and adaptive immune responses. Conversely, some beneficial
microbes, like Lactic Acid Bacteria (LAB) and Bifidobacteria can modulate the immune system
controlling inflammation by means of proteins and non-proteinaceous compounds (Pessione,
2012).
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Several microbiota-derived compounds can contribute to
control host physiological and pathological states: Metabolomic
profiling of gut bacteria can allow to decipher several molecules
(among which short chain fatty acids, for instance those produced
by bacteria belonging to the clostridial cluster IV and XIV,
vitamins and aromatic compounds) controlling cholesterol
synthesis, obesity, cardiovascular diseases, metabolic syndrome.
Curiously, some bioactive peptides or amino acids can be
delivered by food in which LAB are present as fermentation
starters. These bacteria can decrypt peptides from food
proteins, which have anti-oxidant or metal chelating function,
immunomodulatory properties as well as peptides controlling
hyperglycemia, hypercholesterolemia, hypertension, cell cycle,
apoptosis, and even having a refolding action on damaged
proteins. An interesting tannin-degrading activity of bacteria
(e.g., Streptococcus spp. and Fusobacterium spp.) can generate
gallic acid and pyrogallol, both having an anti-carcinogenic
role. Finally, microbial-derived amines can modulate a series of
patho/physiological functions such as allergy, smooth muscle
relaxation, anxiety, appetite, depression (Pessione et al., 2005).
LAB are good producers of gamma-amino butyric acid (GABA)
(Laroute et al., 2016) that contributes to gut-to-brain signaling
through different pathways involving enteric neurons, entero-
endocrine cells and immune cells. Yeasts, mainly Saccharomyces
cerevisiae, can convert tryptophan into melatonin and serotonin
that are informational molecules related to circadian rhythm but
also promising agents for the prevention of neurodegenerative
diseases.
This intense network of molecules, allowing communication
among bacteria, viruses, and eukaryotic cells has evolved to
guarantee optimal life in different ecological niches to each
component of the ecosystem and is based upon effector-receptor
model. In-depth knowledge of all these biochemical signals,
as well as the underlying finalism are still far to be fully
elucidated. Nevertheless, some mechanistic aspects highlighted
in the present topic issue can open new perspectives in medicine
but can also shed light on evolution strategies.
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